Department of Obstetrics and Gynaecology, School of Clinical Medicine, University of KwaZulu Natal, Durban, South Africa.
Biostatistics Unit, South African Medical Research Council, Tygerberg, South Africa.
J Obstet Gynaecol. 2024 Dec;44(1):2361445. doi: 10.1080/01443615.2024.2361445. Epub 2024 Jun 4.
Due to its potential nephrotoxicity, screening for pre-existing renal function disorders has become a routine clinical assessment for initiating Tenofovir diphosphate fumarate (TDF)-containing antiretroviral treatment (ART) or pre-exposure prophylaxis (PrEP) in pregnant and non-pregnant adults. We aimed to establish reference values for commonly used markers of renal function in healthy pregnant women of African origin.
Pregnant women ≥18 years, not living with HIV, and at 14-28 weeks gestation were enrolled in a PrEP clinical trial in Durban, South Africa between September 2017 and December 2019. Women were monitored 4-weekly during pregnancy until six months postpartum. We measured maternal weight and serum creatinine (sCr) at each visit and calculated creatinine clearance (CrCl) rates using the Cockcroft-Gault (CG) and Modification of Diet in Renal Disease (MDRD) formulae. Reference ranges for sCr and CrCl by CG and MDRD calculations were derived from the mean ± 2SD of values for pregnancy and postdelivery.
Between 14--and 40 weeks gestation, 249 African women not exposed to TDF-PrEP contributed a total of 1193 renal function values. Postdelivery, 207 of these women contributed to 800 renal function values. The normal reference range for sCr was 30-57 and 32-60 umol/l in the 2 and 3 trimesters of pregnancy. Normal reference ranges for CrCl using the MDRD calculation were 129-282 and 119-267 ml/min/1.73m for the 2 and 3 trimesters, respectively. Using the CG method of calculation, normal reference ranges for CrCl were 120-304 and 123-309 ml/min/1.73m for the 2 and 3 trimesters respectively. In comparison, the normal reference range for sCr, CrCl by MDRD and CG calculations postpartum was 40-77 umol/l, 92-201, and 90-238 ml/min/1.73m, respectively.
In African women, the Upper Limit of Normal (ULN) for sCr in pregnancy is approximately 20% lower than 6 months postnatally. Inversely, the Lower Limit of Normal (LLN) for CrCl using either MDRD or CG equation is approximately 35% higher than 6 months postnatally. We provide normal reference ranges for sCr and CrCl for both methods of calculation and appropriate for the 2 and 3 trimesters of pregnancy in African women.
由于其潜在的肾毒性,在开始使用富马酸替诺福韦二吡呋酯(TDF)的抗逆转录病毒治疗(ART)或暴露前预防(PrEP)治疗之前,对预先存在的肾功能障碍进行筛查已成为常规临床评估。我们旨在为非洲裔健康孕妇中常用的肾功能标志物建立参考值。
2017 年 9 月至 2019 年 12 月期间,在南非德班进行了一项 PrEP 临床试验,招募了年龄≥18 岁、未感染 HIV 的孕妇,妊娠 14-28 周。孕妇在妊娠期间每 4 周监测一次,直到产后 6 个月。我们在每次就诊时测量孕妇的体重和血清肌酐(sCr),并使用 Cockcroft-Gault(CG)和肾脏病饮食改良公式(MDRD)计算肌酐清除率(CrCl)率。CG 和 MDRD 计算的 sCr 和 CrCl 的参考范围是妊娠和产后的平均值±2SD。
在妊娠 14 至 40 周期间,未接触 TDF-PrEP 的 249 名非洲裔妇女共提供了 1193 个肾功能值。产后,其中 207 名妇女提供了 800 个肾功能值。sCr 的正常参考范围分别为妊娠第 2 和第 3 个三个月的 30-57 和 32-60 umol/L。使用 MDRD 计算的 CrCl 的正常参考范围分别为妊娠第 2 和第 3 个三个月的 129-282 和 119-267 ml/min/1.73m。使用 CG 方法计算,CrCl 的正常参考范围分别为妊娠第 2 和第 3 个三个月的 120-304 和 123-309 ml/min/1.73m。相比之下,产后 sCr、MDRD 和 CG 计算的 CrCl 的正常参考范围分别为 40-77 umol/L、92-201 和 90-238 ml/min/1.73m。
在非洲裔妇女中,妊娠期间 sCr 的上限正常(ULN)比产后 6 个月低约 20%。相反,使用 MDRD 或 CG 方程计算的 CrCl 的下限正常(LLN)比产后 6 个月高约 35%。我们为这两种方法的 sCr 和 CrCl 提供了正常参考范围,适用于非洲裔妇女妊娠的第 2 和第 3 个三个月。